This study aimed to build on previous research by investigating the effects of probiotics, specifically Lactobacillus helveticus R0052 and Bifidobacterium longum R0175, on depression severity and associated mechanisms (e.g., BDNF levels and the HPA axis) in patients diagnosed with MDD who were also receiving fluoxetine. This evidence concerns the gene BDNF and depressive disorder.